Let’s explore “Estrone — lab reference”

Risk-based goals may be <100, <70, or <55 depending on primary/secondary prevention risk.

Higher HDL is not always protective; interpret within the entire risk profile.

150-199 borderline high; 200-499 high; ≥500 severe and pancreatitis-relevant.

Risk-based goals may be lower; useful when triglycerides are elevated.

Often calculated. Less reliable when triglycerides are markedly elevated.

90-99 above desirable; 100-119 borderline high; 120-139 high; ≥140 very high. Risk goals may be lower.

The test method matters. Ask your clinician to read this result with HDL and ApoB.

Approximate risk strata are sex-specific and assay-dependent.

≥75 increased; ≥125 commonly treated as a risk-enhancing level. Units are not directly interchangeable with mg/dL.

≥2 suggests higher cardiovascular risk; >10 may reflect acute inflammation and should generally be repeated when well.

Age, kidney function, obesity, rhythm, and clinical setting affect interpretation.

The test method and the reason for testing affect which cutoff your clinician uses.